• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    UL Solutions Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results, Announces 2026 Growth Outlook and Increases Quarterly Dividend

    2/19/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email

    Fourth Quarter 20251

    • Strong revenue growth of 6.8% to $789 million, including 5.7% organic growth
    • Net income of $71 million, including a $37 million pre-tax restructuring charge, decreased 16.5%, Adjusted Net Income of $114 million increased 11.8%
    • Diluted earnings per share of $0.32 decreased 20.0%, Adjusted Diluted Earnings Per Share of $0.53 increased 8.2%
    • Adjusted EBITDA of $217 million increased 28.4%, Adjusted EBITDA margin of 27.5% expanded 460 basis points

    Full-Year 20252

    • Strong revenue growth of 6.4% to $3,053 million, including 6.2% organic growth
    • Net income of $345 million, including a $35 million pre-tax restructuring charge, unchanged from prior period, Adjusted Net Income of $423 million increased 17.2%
    • Diluted earnings per share of $1.60 decreased 1.2%, Adjusted Diluted Earnings Per Share of $1.99 increased 17.1%
    • Adjusted EBITDA of $792 million increased 20.7%, Adjusted EBITDA margin of 25.9% expanded 300 basis points
    • Record net cash flows provided by operating activities of $600 million
    • Introduces 2026 growth outlook, expecting continued momentum in underlying business performance

    UL Solutions Inc. (NYSE:ULS), a global safety science leader in independent third-party testing, inspection and certification services and related software and advisory offerings, today reported results for the fourth quarter and full-year ended December 31, 2025.

    "I'm incredibly proud of our team's outstanding performance, with fourth quarter and full-year results exceeding guidance," said President and CEO Jennifer Scanlon. "Surpassing $3 billion in annual revenue for the first time is a significant milestone, reflecting our business model's strength and resilience during an environment of changing global dynamics. We delivered safety, security and sustainability solutions backed by trusted, science-based expertise to over 80,000 customers as they brought their products to complex global markets."

    Scanlon added: "We are well positioned in 2026 for continued high-quality growth thanks to strategic investments we've made to support our customers' innovations, including our focus on megatrends such as the global energy transition and rapid AI-fueled digitalization. Our disciplined capital allocation and commitment to operational excellence through continuous improvement reinforce our growth trajectory."

    Chief Financial Officer Ryan Robinson stated: "We delivered record financial results for the full-year 2025 amid sustained demand in all geographic regions, with Adjusted EBITDA margin of 25.9%, an increase of 300 basis points from the prior year, and cash flow from operations of $600 million. Strong organic growth, continued Adjusted EBITDA margin expansion and robust cash flow generation demonstrate the essential role we play helping customers worldwide. Our operational initiatives, including laboratory productivity gains and footprint optimization, drove meaningful Adjusted EBITDA margin improvement. Looking ahead to 2026, we anticipate mid-single digit constant currency organic revenue growth while continuing to improve our Adjusted EBITDA margin, and we remain confident in our ability to deliver sustainable long-term value."

    Fourth Quarter 2025 Financial Results

    Revenue of $789 million compared to $739 million in the fourth quarter of 2024, an increase of 6.8%. Organic growth of 5.7%, led by Consumer and Industrial segments.

    Pre-tax charges associated with the previously announced expense reduction initiative (the "Restructuring Plan") of $37 million.

    Net income of $71 million compared to $85 million in the fourth quarter of 2024, a decrease of 16.5%. Net income margin of 9.0% compared to 11.5% in the fourth quarter of 2024, a decrease of 250 basis points. The margin decrease resulted from an increased income tax rate and restructuring charges noted above, partially offset by higher revenue and operating leverage.

    Adjusted Net Income of $114 million compared to $102 million in the fourth quarter of 2024, an increase of 11.8%. Adjusted Net Income margin of 14.4% compared to 13.8% in the fourth quarter of 2024, an increase of 60 basis points.

    Diluted earnings per share of $0.32 compared to $0.40 in the fourth quarter of 2024, a decrease of $0.08. Adjusted Diluted Earnings Per Share of $0.53 compared to $0.49 in the fourth quarter of 2024, an increase of $0.04.

    Adjusted EBITDA of $217 million compared to $169 million in the fourth quarter of 2024, an increase of 28.4%. Adjusted EBITDA margin of 27.5% compared to 22.9% in the fourth quarter of 2024, an increase of 460 basis points. The margin expansion resulted from higher revenue and operating leverage, led by the Consumer and Industrial segments.

    1 This press release includes references to non-GAAP financial measures. Please refer to "Non-GAAP Financial Measures" later in this release for the definitions of each non-GAAP financial measure presented, as well as reconciliations of these measures to their most directly comparable GAAP measures. All comparisons are to fourth quarter 2024 unless otherwise noted.

    2 All comparisons in the section titled Full-Year 2025 are to full-year 2024 unless otherwise noted.

    Fourth Quarter 2025 Segment Performance

    Industrial Segment Results

    Industrial revenue of $352 million compared to $328 million in the fourth quarter of 2024, an increase of 7.3%, or 6.1% on an organic basis. Operating income of $101 million compared to $88 million in the fourth quarter of 2024. Operating income margin of 28.7% compared to 26.8% in the fourth quarter of 2024. Adjusted EBITDA of $128 million compared to $105 million in the fourth quarter of 2024, an increase of 21.9%. Adjusted EBITDA margin of 36.4% compared to 32.0% in the fourth quarter of 2024. Revenue gains were driven primarily by energy and automation and fire safety. Adjusted EBITDA gains and margin improvement were driven primarily by higher revenue and operating leverage.

    Consumer Segment Results

    Consumer revenue of $335 million compared to $309 million in the fourth quarter of 2024, an increase of 8.4%, or 7.1% on an organic basis. Operating income of $12 million, including charges of $28 million related to the Restructuring Plan, compared to $22 million in the fourth quarter of 2024. Operating income margin of 3.6% compared to 7.1% in the fourth quarter of 2024. Adjusted EBITDA of $66 million compared to $45 million in the fourth quarter of 2024, an increase of 46.7%. Adjusted EBITDA margin of 19.7% compared to 14.6% in the fourth quarter of 2024. Revenue gains were driven primarily by consumer technology, including electromagnetic compatibility testing. Adjusted EBITDA gains and margin improvement were driven primarily by higher revenue and operating leverage.

    Software and Advisory Segment Results

    Software and Advisory revenue of $102 million was the same as the fourth quarter of 2024. Operating income of $5 million was in line with the fourth quarter of 2024. Adjusted EBITDA of $23 million compared to $19 million in the fourth quarter of 2024, an increase of 21.1%. Adjusted EBITDA margin of 22.5% compared to 18.6% in the fourth quarter of 2024. Revenue was in line with the prior year period driven by demand in software, offset by softness in advisory services. Adjusted EBITDA gains and margin improvement were driven primarily by higher billable utilization.

    Liquidity and Capital Resources

    For the year ended December 31, 2025, the Company generated $600 million of net cash provided by operating activities, an increase from $524 million for the same period in 2024. Net cash provided by operating activities for the year ended December 31, 2025 was a result of improved business performance.

    The Company continues to make strategic capital investments to meet increased demand and drive greater productivity. Capital expenditures were $197 million for the year ended December 31, 2025, compared to $237 million for the same period in 2024. Free Cash Flow for the year ended December 31, 2025 was $403 million, compared to $287 million for the same period in 2024.

    The Company paid a dividend of $0.13 per share, or $26 million, during the three months ended December 31, 2025.

    As of December 31, 2025, total debt was $494 million, prior to unamortized debt issuance costs, a decrease from December 31, 2024 due to $253 million of net repayments on the Company's credit facilities.

    The Company ended the quarter with cash and cash-equivalents of $295 million and short-term investments of $8 million, compared to $298 million of cash and cash-equivalents and short-term investments of $0 as of December 31, 2024.

    Increased Quarterly Dividend

    The Company's board of directors has increased the quarterly dividend by 11.5% to $0.145 per share for the first quarter of 2026. The dividend will be paid on March 12, 2026 to stockholders of record as of the close of business on March 2, 2026.

    Employee Health and Safety Software Business Sale

    On February 12, 2026, the Company signed a definitive agreement to sell its Employee Health and Safety software business that was previously accounted for in the Company's Software and Advisory segment. The transaction is expected to close in the second quarter of 2026 and will allow the Company to focus on its core ULTRUSTM software portfolio, which provides customers with risk and compliance software solutions that drive product safety and innovation, supply chain transparency and enterprise sustainability.

    Full-Year 2026 Outlook

    The Company's 2026 outlook includes:

    • Mid-single digit constant currency organic revenue growth
      • Inclusive of approximately 1% revenue reduction from business exits announced in the Restructuring Plan
    • Adjusted EBITDA margin improvement to between 26.5% and 27.0%
    • Effective tax rate of approximately 26%
    • Capital expenditures between 7% and 8% of revenue
    • Continuing to pursue acquisitions and portfolio refinements

    The Company's 2026 outlook is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. There can be no assurance that the Company will achieve the results expressed by this outlook, which may be impacted by, among other things, implementation of the Restructuring Plan. In addition, the recent geopolitical environment and attendant increased levels of uncertainty have caused, and may continue to cause, the Company's customers to modify, delay or cancel plans to purchase services. Accordingly, ongoing uncertainty related to the current geopolitical environment and the associated unpredictability of the macroeconomic environment could have an adverse impact on various aspects of the Company's business in the future, including its results of operations and financial condition. Like many other global businesses, the Company is carefully monitoring the potential impacts.

    The Company does not provide guidance for net income margin, the most directly comparable GAAP measure to Adjusted EBITDA margin, and similarly cannot provide a reconciliation between its forecasted Adjusted EBITDA margin and net income margin without unreasonable effort due to the unavailability of reliable estimates for certain components of net income and the respective reconciliations. These forecasted items are not within the Company's control, may vary greatly between periods and could significantly impact future financial results.

    Conference Call and Webcast

    UL Solutions will host a conference call today at 8:30 am ET to discuss the Company's financial results. The live webcast of the conference call and accompanying presentation materials can be accessed through the UL Solutions Investor Relations website at ir.ul.com. For those unable to access the webcast, the conference call can be accessed by dialing 1-844-825-9789 (domestic) or 1-412-317-5180 (international). An archive of the webcast will be available on the Company's website for 30 days.

    About UL Solutions

    A global leader in applied safety science, UL Solutions Inc. (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves as a recognized symbol of trust in our customers' products and reflects an unwavering commitment to advancing our safety mission. We help our customers innovate, launch new products and services, navigate global markets and complex supply chains, and grow sustainably and responsibly into the future. Our science is your advantage.

    Investors and others should note that UL Solutions intends to routinely announce material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the UL Solutions Investor Relations website. We also intend to use certain social media channels as a means of disclosing information about us and our products to consumers, our customers, investors and the public on our X account (@UL_Solutions) and our LinkedIn account (@ULSolutions). The information posted on social media channels is not incorporated by reference in this press release or in any other report or document we file with the SEC. While not all of the information that the Company posts to the UL Solutions Investor Relations website or to social media accounts is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media, and others interested in UL Solutions to review the information shared on our Investor Relations website at ir.ul.com and to regularly follow our social media accounts. Users can automatically receive email alerts and information about the Company by subscribing to "Investor Email Alerts" at the bottom of the UL Solutions Investor Relations website at ir.ul.com.

    Forward-Looking Statements

    This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. These include statements regarding management's objectives for future operations and the Company's plans, business strategy, outlook and future results of operations and financial position, including without limitation, the statements under the heading "Full-Year 2026 Outlook," statements about the Company's expectations with respect to the Restructuring Plan, including the Company's estimates of the charges and expenditures in connection therewith and the timing thereof and the Company's estimates of the benefits of such Restructuring Plan, the payment of quarterly dividends, and the Company's plans to sell its Employee Health and Safety software business, including the Company's estimates of the timing thereof and the expected benefits of such sale. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "would," "likely," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "continues," "outlook" and variations of these terms and similar expressions, or the negative of these terms or similar expressions (although not all forward-looking statements may contain such words). The Company cautions you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.

    There are or will be important factors that could cause the Company's actual results to differ materially from those expressed or implied by the forward-looking statements made in this press release, including, but not limited to, the following: any failure on the Company's part to protect and maintain its brand and reputation, or the impact on its brand or reputation of third-party events or actions outside of its control; risks associated with the Company's information technology and software, including those relating to any future data breach or other cybersecurity incident; the potential disruption of the industries in which the Company operates by technological advances in artificial intelligence; the Company's ability to innovate, adapt to changing customer needs and successfully introduce new products and services in response to changes in the Company's industries and technological advances; the Company's ability to compete in its industries and the effects of increased competition from its competitors; risks associated with conducting business outside the United States, including those relating to fluctuations in foreign currency exchange rates; the imposition of tariffs and enhanced trade, import or export restrictions or changes in U.S. trade policy or similar government actions; and global, regional or political instability and geopolitical tensions; risks related to sustainability; risks associated with the Company's operations in China, which subject the Company and UL-CCIC Company Limited, the Company's joint venture with the China Certification & Inspection (Group) Co., Ltd. ("CCIC"), to China's complex and rapidly evolving laws, which may be interpreted, applied or enforced inconsistently or in ways inconsistent with its current operations, as well as risks associated with the fact that the Chinese government has the power to exercise significant oversight and discretion over, and intervene in and influence, its business operations in China; the relationship between the United States and China and between the Company and CCIC, as well as changes in U.S. and Chinese regulations affecting the Company's business operations in China; any failure on the Company's part to attract, hire or retain its key employees, including its senior leadership and its skilled and trained engineering, technical and professional personnel; the level of the Company's customers' satisfaction and any failure on its part to properly and timely perform its services, meet its contractual obligations or fulfil its customers' needs; changes to the relevant regulatory frameworks or private sector requirements, including any requirement that the Company accept third-party test results or certifications of components, end products, processes or systems or any changes that result in a reduction in required inspections, tests or certifications or harmonized international or cross-industry benchmarks and standards; the Company's ability to adequately maintain, protect and enhance its intellectual property, including its registered UL-in-a-circle certification mark and other certification marks; the Company's ability to implement its growth strategies and initiatives successfully; the Company's reliance on third parties, including subcontractors and outside laboratories; the Company's ability to obtain and maintain the requisite licenses, approvals, accreditations and delegations of authority necessary to conduct its business; the outcomes of current and future legal proceedings; the Company's level of indebtedness and future cash needs; failure to generate sufficient cash to service the Company's indebtedness; a change in the assumptions the Company uses to value its goodwill or intangible assets, or the impairment of its goodwill or intangible assets; the Company's ability to generate sufficient cash to service its indebtedness and invest in the ongoing needs of its business; the increased expenses and responsibilities associated with being a public company; the significant influence that ULSE Inc., its parent and controlling stockholder, has over the Company, including pursuant to its rights under the Company's amended and restated certificate of incorporation and the Stockholder Agreement with ULSE Inc.; natural disasters and other catastrophic events, including pandemics and the rapid spread of contagious illnesses; changes in tax laws in jurisdictions in which the Company operates or adverse outcomes resulting from examination of the Company's or its affiliates' tax returns; risks that the Company may be unable to implement the Restructuring Plan on the anticipated timing; that local law and consultation requirements, including for potential position eliminations, extends the restructuring process further in certain countries or causes the actual charges and expenditures that the Company incurs in connection with the Restructuring Plan, and the timing thereof, to differ materially from estimates; that the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Restructuring Plan and that the Company may not be able to realize the anticipated benefits of the Restructuring Plan; and other factors discussed in the Company's filings with the Securities and Exchange Commission (the "SEC"), including those set forth under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and under "Risk Factors" in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2025, as well as other factors described from time to time in the Company's filings with the SEC.

    If one or more events related to these or other risks or uncertainties materialize, or if the Company's underlying assumptions prove to be incorrect, actual results may differ materially from what the Company anticipates. Many of the important factors that will determine these results are beyond the Company's ability to control or predict. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, the Company does not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. If the Company updates one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect to those or other forward-looking statements. New factors emerge from time to time, and it is not possible for the Company to predict which will arise. In addition, the Company cannot assess the impact of each factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements attributable to the Company, or others acting on the Company's behalf, are expressly qualified in their entirety by the cautionary statements above.

    Non-GAAP Financial Measures

    In addition to financial measures determined in accordance with accounting principles generally accepted in the United States of America ("GAAP"), this press release includes supplemental non-GAAP financial measures, including the presentation of Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted Net Income margin, Adjusted Diluted Earnings Per Share, Free Cash Flow and Free Cash Flow margin. Management uses non-GAAP financial measures in addition to GAAP measures to understand and compare operating results across periods and for forecasting and other purposes. Management believes these non-GAAP financial measures provide useful information to investors and reflect results in a manner that enables, in some instances, more meaningful analysis of trends and facilitates comparison of results across periods. These measures are not financial measures calculated in accordance with GAAP and should not be considered as a substitute for net income, operating income, diluted earnings per share, net cash provided by operating activities or any other measure calculated in accordance with GAAP, and may not be comparable to similarly titled measures reported by other companies due to potential differences between the companies in calculations.

    The Company uses Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted Net Income margin and Adjusted Diluted Earnings Per Share to measure the operational strength and performance of its business and believes these measures provide additional information to investors about certain non-cash items and unusual items that the Company does not expect to continue at the same level in the future. Further, management believes these non-GAAP financial measures provide a meaningful measure of business performance. The Company uses Free Cash Flow and Free Cash Flow margin as additional liquidity measures and believes they provide useful information to investors about the cash generated from the Company's core operations that may be available to repay debt, make other investments and return cash to stockholders.

    There are material limitations to using these non-GAAP financial measures. Adjusted EBITDA does not take into account certain significant items, including depreciation and amortization, interest expense, other expense (income), net, income tax expense, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income, as applicable. Adjusted Net Income and Adjusted Diluted Earnings Per Share do not take into account certain significant items, including other expense (income), net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income and diluted earnings per share, as applicable. Free Cash Flow adjusts for cash items that are ultimately within management's discretion to direct and therefore may imply that there is less or more cash that is available than the most comparable GAAP measure. Free Cash Flow is not intended to represent residual cash flow for discretionary expenditures since debt repayment requirements and other non-discretionary expenditures are not deducted. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering these non-GAAP financial measures in conjunction with net income, operating income, diluted earnings per share and net cash provided by operating activities as calculated in accordance with GAAP.

    See additional information below for definitions of these non-GAAP financial measures, and reconciliations to their most directly comparable GAAP measures.

    UL Solutions Inc.

    Condensed Consolidated Statements of Operations

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

    (in millions, except per share data)

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue

    $

    789

     

     

    $

    739

     

     

    $

    3,053

     

     

    $

    2,870

     

    Cost of revenue

     

    395

     

     

     

    389

     

     

     

    1,543

     

     

     

    1,478

     

    Selling, general and administrative expenses

     

    239

     

     

     

    235

     

     

     

    953

     

     

     

    931

     

    Restructuring

     

    37

     

     

     

    —

     

     

     

    35

     

     

     

    (1

    )

    Operating income

     

    118

     

     

     

    115

     

     

     

    522

     

     

     

    462

     

    Interest expense

     

    (9

    )

     

     

    (13

    )

     

     

    (41

    )

     

     

    (55

    )

    Other (expense) income, net

     

    (4

    )

     

     

    (10

    )

     

     

    (11

    )

     

     

    8

     

    Income before income taxes

     

    105

     

     

     

    92

     

     

     

    470

     

     

     

    415

     

    Income tax expense

     

    34

     

     

     

    7

     

     

     

    125

     

     

     

    70

     

    Net income

     

    71

     

     

     

    85

     

     

     

    345

     

     

     

    345

     

    Less: net income attributable to non-controlling interests

     

    5

     

     

     

    4

     

     

     

    20

     

     

     

    19

     

    Net income attributable to stockholders of UL Solutions

    $

    66

     

     

    $

    81

     

     

    $

    325

     

     

    $

    326

     

     

     

     

     

     

     

     

     

    Earnings per common share:

     

     

     

     

     

     

     

    Basic

    $

    0.33

     

     

    $

    0.41

     

     

    $

    1.62

     

     

    $

    1.63

     

    Diluted

    $

    0.32

     

     

    $

    0.40

     

     

    $

    1.60

     

     

    $

    1.62

     

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding:

     

     

     

     

     

     

     

    Basic

     

    201

     

     

     

    200

     

     

     

    201

     

     

     

    200

     

    Diluted

     

    204

     

     

     

    202

     

     

     

    203

     

     

     

    201

     

    UL Solutions Inc.

    Condensed Consolidated Balance Sheets

    (Unaudited)

     

    (in millions)

    December 31, 2025

     

    December 31, 2024

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    295

     

    $

    298

    Accounts receivable, net

     

    422

     

     

    380

    Contract assets, net

     

    204

     

     

    182

    Other current assets

     

    79

     

     

    61

    Total current assets

     

    1,000

     

     

    921

    Property, plant and equipment, net

     

    699

     

     

    631

    Goodwill

     

    656

     

     

    633

    Intangible assets, net

     

    48

     

     

    58

    Operating lease right-of-use assets

     

    179

     

     

    186

    Deferred income taxes

     

    94

     

     

    108

    Capitalized software, net

     

    105

     

     

    127

    Other assets

     

    140

     

     

    136

    Total Assets

    $

    2,921

     

    $

    2,800

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Current portion of long-term debt

    $

    —

     

    $

    50

    Accounts payable

     

    183

     

     

    182

    Accrued compensation and benefits

     

    282

     

     

    254

    Operating lease liabilities - current

     

    43

     

     

    38

    Contract liabilities

     

    173

     

     

    162

    Other current liabilities

     

    79

     

     

    54

    Total current liabilities

     

    760

     

     

    740

    Long-term debt

     

    491

     

     

    692

    Pension and postretirement benefit plans

     

    134

     

     

    196

    Operating lease liabilities

     

    149

     

     

    155

    Other liabilities

     

    93

     

     

    86

    Total Liabilities

     

    1,627

     

     

    1,869

    Total Stockholders' Equity

     

    1,294

     

     

    931

    Total Liabilities and Stockholders' Equity

    $

    2,921

     

    $

    2,800

    UL Solutions Inc.

    Condensed Consolidated Statements of Cash Flows

    (Unaudited)

     

     

    Year Ended December 31,

    (in millions)

     

    2025

     

     

     

    2024

     

    Operating activities

     

     

     

    Net cash flows provided by operating activities

    $

    600

     

     

    $

    524

     

     

     

     

     

    Investing activities

     

     

     

    Capital expenditures

     

    (197

    )

     

     

    (237

    )

    Acquisitions, net of cash acquired

     

    (1

    )

     

     

    (26

    )

    Proceeds from divestitures

     

    —

     

     

     

    29

     

    Purchases of investments, net

     

    (7

    )

     

     

    —

     

    Other investing activities, net

     

    1

     

     

     

    —

     

    Net cash flows used in investing activities

     

    (204

    )

     

     

    (234

    )

     

     

     

     

    Financing activities

     

     

     

    Repayments of long-term debt, net

     

    (253

    )

     

     

    (165

    )

    Dividends to stockholders of UL Solutions

     

    (104

    )

     

     

    (100

    )

    Dividends to non-controlling interest

     

    (17

    )

     

     

    (15

    )

    Employee taxes paid on settlement of stock-based compensation

     

    (15

    )

     

     

    —

     

    Other financing activities, net

     

    (7

    )

     

     

    (4

    )

    Net cash flows used in financing activities

     

    (396

    )

     

     

    (284

    )

     

     

     

     

    Effect of exchange rate changes on cash and cash equivalents

     

    (3

    )

     

     

    (23

    )

     

     

     

     

    Net decrease in cash and cash equivalents

     

    (3

    )

     

     

    (17

    )

     

     

     

     

    Cash and cash equivalents

     

     

     

    Beginning of period

     

    298

     

     

     

    315

     

    End of period

    $

    295

     

     

    $

    298

     

    UL Solutions Inc.

    Supplemental Financial Information

    Revenue by Major Service Category and Revenue Growth Components

    (Unaudited)

     

    Revenue by Major Service Category

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

    (in millions)

     

    2025

     

     

    2024

     

     

    2025

     

     

    2024

    Certification Testing

    $

    223

     

    $

    199

     

    $

    851

     

    $

    784

    Ongoing Certification Services

     

    259

     

     

    248

     

     

    1,006

     

     

    953

    Non-certification Testing and Other Services

     

    232

     

     

    221

     

     

    911

     

     

    860

    Software

     

    75

     

     

    71

     

     

    285

     

     

    273

    Total

    $

    789

     

    $

    739

     

    $

    3,053

     

    $

    2,870

    Revenue Change Components

    Three Months Ended December 31, 2025

     

     

     

     

    (in millions)

    Organic1

     

     

    FX3

     

    Total

     

    Organic %

    Change

     

    Total %

    Change

    Revenue change

     

     

     

     

     

     

     

     

     

     

    Industrial

    $

    20

     

     

    $

    4

     

    $

    24

     

    6.1

    %

     

    7.3

    %

    Consumer

     

    22

     

     

     

    4

     

     

    26

     

    7.1

    %

     

    8.4

    %

    Software and Advisory

     

    —

     

     

     

    —

     

     

    —

     

    —

    %

     

    —

    %

    Total

    $

    42

     

     

    $

    8

     

    $

    50

     

    5.7

    %

     

    6.8

    %

    Revenue Change Components

    Year Ended December 31, 2025

     

     

     

     

    (in millions)

    Organic1

     

    Acquisition /

    Divestiture2

     

    FX3

     

    Total

     

    Organic %

    Change

     

    Total %

    Change

    Revenue change

     

     

     

     

     

     

     

     

     

     

     

    Industrial

    $

    89

     

    $

    (8

    )

     

    $

    6

     

    $

    87

     

    7.1

    %

     

    6.9

    %

    Consumer

     

    76

     

     

    —

     

     

     

    5

     

     

    81

     

    6.1

    %

     

    6.5

    %

    Software and Advisory

     

    14

     

     

    —

     

     

     

    1

     

     

    15

     

    3.7

    %

     

    4.0

    %

    Total

    $

    179

     

    $

    (8

    )

     

    $

    12

     

    $

    183

     

    6.2

    %

     

    6.4

    %

    __________

    1.

    Organic reflects revenue change in a given period excluding Acquisition / Divestiture and FX in that same period, expressed in dollars or as a percentage of revenue in the prior period.

    2.

    Acquisition / Divestiture is calculated as revenue change in a given period related to acquisitions or disposals of businesses using prior period exchange rates, expressed in dollars or as a percentage of revenue in the prior period. Revenues from an acquisition or disposal are measured as Acquisition / Divestiture for the initial twelve month period following the acquisition or disposal date. Subsequently, the revenue impact from the acquired or disposed business is measured as Organic.

    3.

    FX reflects the impact that foreign currency exchange rates have on revenue in a given period, expressed in dollars or as a percentage of revenue in the prior period. The Company uses constant currency to calculate the FX impact on revenue in a given period by translating current period revenues at prior period exchange rates, expressed as a percentage of revenue in the prior period.

    UL Solutions Inc.

    Supplemental Financial Information

    Non-GAAP Financial Measures

    (Unaudited)

     

    The table below reconciles net income to Adjusted EBITDA.

     

     

     

     

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

    (in millions, unless otherwise stated)

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net income

    $

    71

     

     

    $

    85

     

     

    $

    345

     

     

    $

    345

     

    Depreciation and amortization expense

     

    51

     

     

     

    47

     

     

     

    188

     

     

     

    172

     

    Interest expense

     

    9

     

     

     

    13

     

     

     

    41

     

     

     

    55

     

    Other expense (income), net

     

    4

     

     

     

    10

     

     

     

    11

     

     

     

    (8

    )

    Income tax expense

     

    34

     

     

     

    7

     

     

     

    125

     

     

     

    70

     

    Stock-based compensation

     

    11

     

     

     

    7

     

     

     

    47

     

     

     

    23

     

    Restructuring

     

    37

     

     

     

    —

     

     

     

    35

     

     

     

    (1

    )

    Adjusted EBITDA1

    $

    217

     

     

    $

    169

     

     

    $

    792

     

     

    $

    656

     

    Revenue

    $

    789

     

     

    $

    739

     

     

    $

    3,053

     

     

    $

    2,870

     

    Net income margin

     

    9.0

    %

     

     

    11.5

    %

     

     

    11.3

    %

     

     

    12.0

    %

    Adjusted EBITDA margin2

     

    27.5

    %

     

     

    22.9

    %

     

     

    25.9

    %

     

     

    22.9

    %

    __________

    1.

    The Company defines Adjusted EBITDA as net income adjusted for depreciation and amortization expense, interest expense, other expense (income), net, income tax expense, as well as stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses, as applicable. The Company believes that the presentation of Adjusted EBITDA provides additional information to investors about certain non-cash items and unusual items that are not expected to continue at the same level in the future. Further, the Company believes Adjusted EBITDA provides a meaningful measure of business performance and provides a basis for comparing its performance to that of other peer companies using similar measures. There are material limitations to using Adjusted EBITDA. Adjusted EBITDA does not take into account certain significant items, including depreciation and amortization, interest expense, other expense (income), net, income tax expense, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income, as applicable. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Adjusted EBITDA in conjunction with net income as calculated in accordance with GAAP.

    2.

    Adjusted EBITDA margin is calculated as Adjusted EBITDA as a percentage of revenue.

    The table below reconciles segment operating income to segment Adjusted EBITDA.

     

     

     

     

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

    (in millions, unless otherwise stated)

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Industrial

     

     

     

     

     

     

     

    Segment operating income

    $

    101

     

     

    $

    88

     

     

    $

    386

     

     

    $

    338

     

    Depreciation and amortization expense

     

    15

     

     

     

    14

     

     

     

    56

     

     

     

    47

     

    Stock-based compensation

     

    5

     

     

     

    3

     

     

     

    19

     

     

     

    9

     

    Restructuring

     

    7

     

     

     

    —

     

     

     

    7

     

     

     

    —

     

    Adjusted EBITDA1

    $

    128

     

     

    $

    105

     

     

    $

    468

     

     

    $

    394

     

    Revenue

    $

    352

     

     

    $

    328

     

     

    $

    1,341

     

     

    $

    1,254

     

    Operating income margin

     

    28.7

    %

     

     

    26.8

    %

     

     

    28.8

    %

     

     

    27.0

    %

    Adjusted EBITDA margin2

     

    36.4

    %

     

     

    32.0

    %

     

     

    34.9

    %

     

     

    31.4

    %

     

     

     

     

     

     

     

     

    Consumer

     

     

     

     

     

     

     

    Segment operating income

    $

    12

     

     

    $

    22

     

     

    $

    122

     

     

    $

    114

     

    Depreciation and amortization expense

     

    22

     

     

     

    20

     

     

     

    81

     

     

     

    79

     

    Stock-based compensation

     

    4

     

     

     

    3

     

     

     

    20

     

     

     

    11

     

    Restructuring

     

    28

     

     

     

    —

     

     

     

    26

     

     

     

    (1

    )

    Adjusted EBITDA1

    $

    66

     

     

    $

    45

     

     

    $

    249

     

     

    $

    203

     

    Revenue

    $

    335

     

     

    $

    309

     

     

    $

    1,319

     

     

    $

    1,238

     

    Operating income margin

     

    3.6

    %

     

     

    7.1

    %

     

     

    9.2

    %

     

     

    9.2

    %

    Adjusted EBITDA margin2

     

    19.7

    %

     

     

    14.6

    %

     

     

    18.9

    %

     

     

    16.4

    %

     

     

     

     

     

     

     

     

    Software and Advisory

     

     

     

     

     

     

     

    Segment operating income

    $

    5

     

     

    $

    5

     

     

    $

    14

     

     

    $

    10

     

    Depreciation and amortization expense

     

    14

     

     

     

    13

     

     

     

    51

     

     

     

    46

     

    Stock-based compensation

     

    2

     

     

     

    1

     

     

     

    8

     

     

     

    3

     

    Restructuring

     

    2

     

     

     

    —

     

     

     

    2

     

     

     

    —

     

    Adjusted EBITDA1

    $

    23

     

     

    $

    19

     

     

    $

    75

     

     

    $

    59

     

    Revenue

    $

    102

     

     

    $

    102

     

     

    $

    393

     

     

    $

    378

     

    Operating income margin

     

    4.9

    %

     

     

    4.9

    %

     

     

    3.6

    %

     

     

    2.6

    %

    Adjusted EBITDA margin2

     

    22.5

    %

     

     

    18.6

    %

     

     

    19.1

    %

     

     

    15.6

    %

     

     

     

     

     

     

     

     

    Adjusted EBITDA1

    $

    217

     

     

    $

    169

     

     

    $

    792

     

     

    $

    656

     

    __________

    1.

    See definition on previous page.

    2.

    See definition on previous page.

    The table below reconciles net income to Adjusted Net Income.

     

     

     

     

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

    (in millions, unless otherwise stated)

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net income

    $

    71

     

     

    $

    85

     

     

    $

    345

     

     

    $

    345

     

    Other expense (income), net

     

    4

     

     

     

    10

     

     

     

    11

     

     

     

    (8

    )

    Stock-based compensation

     

    11

     

     

     

    7

     

     

     

    47

     

     

     

    23

     

    Restructuring

     

    37

     

     

     

    —

     

     

     

    35

     

     

     

    (1

    )

    Tax effect of adjustments3

     

    (9

    )

     

     

    —

     

     

     

    (15

    )

     

     

    2

     

    Adjusted Net Income1

    $

    114

     

     

    $

    102

     

     

    $

    423

     

     

    $

    361

     

    Revenue

    $

    789

     

     

    $

    739

     

     

    $

    3,053

     

     

    $

    2,870

     

    Net income margin

     

    9.0

    %

     

     

    11.5

    %

     

     

    11.3

    %

     

     

    12.0

    %

    Adjusted Net Income margin2

     

    14.4

    %

     

     

    13.8

    %

     

     

    13.9

    %

     

     

    12.6

    %

    __________

    1.

    The Company defines Adjusted Net Income as net income adjusted for other expense (income), net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses, as applicable, adjusted to give effect to the income tax impact of such adjustments. The Company believes that the presentation of Adjusted Net Income provides additional information to investors about certain non-cash items and unusual items that are expected to continue at the same level in the future. Further, the Company believes Adjusted Net Income provides a meaningful measure of business performance and provides a basis for comparing its performance to that of other peer companies using similar measures. There are material limitations to using Adjusted Net Income. Adjusted Net Income does not take into account certain significant items, including other expense (income), net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income, as applicable. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Adjusted Net Income in conjunction with net income as calculated in accordance with GAAP.

    2.

    Adjusted Net Income margin is calculated as Adjusted Net Income as a percentage of revenue.

    3.

    The Company computed the tax effect of adjustments to net earnings by applying the statutory tax rate in the relevant jurisdictions to the taxable income or expense items that are adjusted in the period presented. If a valuation allowance exists, the rate applied is zero.

    The table below reconciles diluted earnings per share to Adjusted Diluted Earnings Per Share.

     

     

     

     

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

    2025

     

     

     

    2024

     

    Diluted earnings per share

    $

    0.32

     

     

    $

    0.40

     

    $

    1.60

     

     

    $

    1.62

     

    Other expense (income), net

     

    0.02

     

     

     

    0.05

     

     

    0.06

     

     

     

    (0.04

    )

    Stock-based compensation

     

    0.05

     

     

     

    0.04

     

     

    0.23

     

     

     

    0.12

     

    Restructuring

     

    0.18

     

     

     

    —

     

     

    0.17

     

     

     

    (0.01

    )

    Tax effect of adjustments2

     

    (0.04

    )

     

     

    —

     

     

    (0.07

    )

     

     

    0.01

     

    Adjusted Diluted Earnings Per Share1

    $

    0.53

     

     

    $

    0.49

     

    $

    1.99

     

     

    $

    1.70

     

    __________

    1.

    The Company defines Adjusted Diluted Earnings Per Share as diluted earnings per share attributable to stockholders of UL Solutions adjusted for other expense (income), net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses, as applicable, adjusted to give effect to the income tax impact of such adjustments. The Company believes that the presentation of Adjusted Diluted Earnings Per Share provides additional information to investors about certain non-cash items and unusual items that are expected to continue at the same level in the future. Further, the Company believes Adjusted Diluted Earnings Per Share provides a meaningful measure of business performance and provides a basis for comparing its performance to that of other peer companies using similar measures. There are material limitations to using Adjusted Diluted Earnings Per Share. Adjusted Diluted Earnings Per Share does not take into account certain significant items, including other expense (income), net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's diluted earnings per share, as applicable. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Adjusted Diluted Earnings Per Share in conjunction with diluted earnings per share as calculated in accordance with GAAP.

    2.

    See definition on previous page.

    The table below reconciles net cash provided by operating activities to Free Cash Flow.

     

     

     

    Year Ended

    December 31,

    (in millions)

     

    2025

     

     

     

    2024

     

    Net cash provided by operating activities

    $

    600

     

     

    $

    524

     

    Capital expenditures

     

    (197

    )

     

     

    (237

    )

    Free Cash Flow1

    $

    403

     

     

    $

    287

     

    Revenue

    $

    3,053

     

     

    $

    2,870

     

    Net cash provided by operating activities margin

     

    19.7

    %

     

     

    18.3

    %

    Free Cash Flow margin2

     

    13.2

    %

     

     

    10.0

    %

    __________

    1.

    The Company defines Free Cash Flow as cash from operating activities less cash outlays related to capital expenditures. The Company defines capital expenditures to include purchases of property, plant and equipment and capitalized software. These items are subtracted from cash from operating activities because they represent long-term investments that are required for normal business activities. The Company uses Free Cash Flow as an additional liquidity measure and believes it provides useful information to investors about the cash generated from its core operations that may be available to repay debt, make other investments and return cash to stockholders. There are material limitations to using Free Cash Flow. Free Cash Flow adjusts for cash items that are ultimately within management's discretion to direct, and therefore, may imply that there is less or more cash that is available than the most comparable GAAP measure. Free Cash Flow is not intended to represent residual cash flow for discretionary expenditures since debt repayment requirements and other non-discretionary expenditures are not deducted. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Free Cash Flow in conjunction with net cash provided by operating activities as calculated in accordance with GAAP.

    2.

    Free Cash Flow margin is calculated as Free Cash Flow as a percentage of revenue.

    Source Code: ULS-IR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260219359717/en/

    Media:

    Kathy Fieweger

    Senior Vice President and Chief Corporate Communications Officer

    [email protected]

    +1 312-852-5156

    Investors:

    Yijing Brentano

    Vice President, Investor Relations

    [email protected]

    +1 312-895-9873

    Get the next $ULS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    2/17/2026$86.00Buy
    BofA Securities
    12/17/2025$97.00Neutral → Outperform
    Robert W. Baird
    11/5/2025$84.00Overweight → Neutral
    Analyst
    5/14/2025$71.00Buy → Neutral
    Citigroup
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on UL Solutions Inc. with a new price target

    BofA Securities resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $86.00

    2/17/26 7:29:05 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded UL Solutions Inc. from Neutral to Outperform and set a new price target of $97.00

    12/17/25 8:48:07 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. downgraded by Analyst with a new price target

    Analyst downgraded UL Solutions Inc. from Overweight to Neutral and set a new price target of $84.00

    11/5/25 7:29:40 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Shannon James M

    4 - UL Solutions Inc. (0001901440) (Issuer)

    1/7/26 7:10:05 PM ET
    $ULS
    Precision Instruments
    Health Care

    Executive VP & CFO Robinson Ryan D gifted 135,956 shares and received a gift of 135,956 shares, decreasing direct ownership by 99% to 1,000 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    1/7/26 7:10:07 PM ET
    $ULS
    Precision Instruments
    Health Care

    EVP & CCO Uggetti Alberto converted options into 1,007 shares and covered exercise/tax liability with 247 shares, increasing direct ownership by 8% to 10,045 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    1/5/26 5:40:09 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UL Solutions Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results, Announces 2026 Growth Outlook and Increases Quarterly Dividend

    Fourth Quarter 20251 Strong revenue growth of 6.8% to $789 million, including 5.7% organic growth Net income of $71 million, including a $37 million pre-tax restructuring charge, decreased 16.5%, Adjusted Net Income of $114 million increased 11.8% Diluted earnings per share of $0.32 decreased 20.0%, Adjusted Diluted Earnings Per Share of $0.53 increased 8.2% Adjusted EBITDA of $217 million increased 28.4%, Adjusted EBITDA margin of 27.5% expanded 460 basis points Full-Year 20252 Strong revenue growth of 6.4% to $3,053 million, including 6.2% organic growth Net income of $345 million, including a $35 million pre-tax restructuring charge, unchanged from prior period, Adju

    2/19/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Sets Date for Fourth Quarter and Full Year 2025 Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the fourth quarter and full year 2025 before the market opens on Thursday, Feb. 19. Management will host a webcast and conference call that same day at 8:30 a.m. EST (7:30 a.m. CST) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the confere

    2/5/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Debuts Testing and Certification Framework for Safer Plug-In Solar Across the United States

    UL Solutions has launched a dedicated testing and certification program for plug-in solar systems, also known as balcony solar, creating a clear safety framework to support their installation and use across the United States. The program establishes construction, performance and labeling criteria that help manufacturers design plug-in solar products meeting safety standards. By addressing safety risks associated with plug-in solar systems, UL Solutions is helping to enable safer, more accessible solar power options for residents of multi-unit buildings and supporting emerging state-level legislation. UL Solutions (NYSE:ULS), a global leader in applied safety science, today announc

    1/8/26 4:15:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    SEC Filings

    View All

    UL Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UL Solutions Inc. (0001901440) (Filer)

    2/19/26 6:56:37 AM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.

    SCHEDULE 13G/A - UL Solutions Inc. (0001901440) (Subject)

    2/13/26 4:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.

    SCHEDULE 13G/A - UL Solutions Inc. (0001901440) (Subject)

    2/13/26 4:05:29 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Financials

    Live finance-specific insights

    View All

    UL Solutions Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results, Announces 2026 Growth Outlook and Increases Quarterly Dividend

    Fourth Quarter 20251 Strong revenue growth of 6.8% to $789 million, including 5.7% organic growth Net income of $71 million, including a $37 million pre-tax restructuring charge, decreased 16.5%, Adjusted Net Income of $114 million increased 11.8% Diluted earnings per share of $0.32 decreased 20.0%, Adjusted Diluted Earnings Per Share of $0.53 increased 8.2% Adjusted EBITDA of $217 million increased 28.4%, Adjusted EBITDA margin of 27.5% expanded 460 basis points Full-Year 20252 Strong revenue growth of 6.4% to $3,053 million, including 6.2% organic growth Net income of $345 million, including a $35 million pre-tax restructuring charge, unchanged from prior period, Adju

    2/19/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Sets Date for Fourth Quarter and Full Year 2025 Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the fourth quarter and full year 2025 before the market opens on Thursday, Feb. 19. Management will host a webcast and conference call that same day at 8:30 a.m. EST (7:30 a.m. CST) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the confere

    2/5/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.13 per share. The dividend will be paid on Dec. 8 to shareholders of record as of the close of business on Nov. 28. About UL Solutions A global leader in applied safety science, UL Solutions (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves as

    11/11/25 4:45:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    UL Solutions Breaks Ground on Global Fire Science Center of Excellence in Illinois

    The advanced fire safety testing and R&D facility will be dedicated to identifying, evaluating and mitigating fire risks. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory investments to date, helping to reduce fire risks globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826231103/en/UL Solutions has announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory i

    8/26/25 5:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    3/11/25 9:15:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/13/24 12:26:41 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 5:49:12 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form SC 13G filed by UL Solutions Inc.

    SC 13G - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 10:34:15 AM ET
    $ULS
    Precision Instruments
    Health Care